Stoke, Biogen share 4-year data on zorevunersen for Dravet syndrome
Go back to Stoke, Biogen share 4-year data on zorevunersen for Dravet syndrome| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 225.36 +6.29 (2.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $219.07 | 52 Week High | $333.65 | |||
| Open | $219.22 | 52 Week Low | $223.02 | |||
| Day High | $226.43 | P/E | 28.86 | |||
| Day Low | $219.00 | EPS | $7.81 | |||
| Volume | 1,112,309 | |||||
| (NASDAQ: STOK) | Delayed: 29.20 +1.15 (4.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.05 | 52 Week High | $ | |||
| Open | $28.44 | 52 Week Low | $ | |||
| Day High | $29.40 | P/E | N/A | |||
| Day Low | $28.24 | EPS | $ | |||
| Volume | 527,225 | |||||

